Skip to content
Osmind logo

Osmind

Osmind is a YC Summer 2020 (S20) company. Based in San Francisco, CA, USA. Team of 55.

  • Mental Health Tech
  • SaaS
  • Health Tech

About Osmind

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Osmind builds an electronic health record and billing platform for interventional psychiatry practices offering treatments such as Spravato, TMS, and ketamine. The platform handles charting, prior authorization, insurance reimbursement, and patient outcome tracking, replacing generic EHR workflows that were not designed for these treatment modalities. Clinics also feed anonymized real-world data into research studies that inform clinical standards for emerging psychiatric treatments.

Business model

Subscription-based SaaS with optional billing services for practices

Go-to-market

Independent interventional psychiatry practices are the direct buyers; the platform is offered with transparent pricing and supplemented by an operational network that helps clinics launch new treatment modalities, combining self-serve onboarding with hands-on support for billing and compliance.

From the Y Combinator listing

How Osmind describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Platform for breakthrough mental health research and treatment

Osmind is the premier platform for clinicians and researchers advancing new life-saving mental health treatments. Today, mental health disorders are one of the leading causes of death worldwide, especially among young adults, and are tied to shortening lifespans. While there have been developments in new psychiatric medications since the first FDA approval in 1954, today there is a growing movement among clinicians, patients, and researchers who are recognizing the need to accelerate new science. The Osmind treatment platform is the first and only solution that solves specific challenges faced by neuropsychiatric clinics, spanning general psychiatry and interventional psychiatry (transcranial magnetic stimulation, ketamine, SPRAVATO®, psychedelic medicine, electroconvulsive therapy). The core electronic health record (EHR) technology is precisely developed for interventional treatment workflows and designed to support a strong therapeutic alliance, including journaling tools and assistance with health plan reimbursement, which is a significant access hurdle for millions of patients. Research from our platform is already helping to set new standards for mental health interventions. For example, in the largest published real-world analysis of ketamine infusion therapy for depression, we teamed up with Stanford University School of Medicine to share findings in the Journal of Affective Disorders (March 2022). We have multiple ongoing research studies leveraging our proprietary real-world data, including an even larger ketamine analysis leveraging machine learning to predict treatment outcomes. Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists. We are backed by top investors including DFJ Growth, General Catalyst, Future Ventures, Tiger Global, and Y Combinator.

Facts

Industry
Healthcare / Healthcare -> Healthcare IT
Location
San Francisco, CA, USA
Team size
55
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works